Recently, the Second Circuit, Sixth Circuit, and a Texas district again rejected the pharmaceutical industry’s challenges to ...

Medicare is expanding its drug price negotiation program to include 15 more medications, including popular drugs like Ozempic.

A new study finds Medicare beneficiaries are facing higher deductibles and cost-sharing requirements following changes ...

President Trump may aggressively negotiate lower drug prices in Medicare using a program that Democrats created and Trump ...

Merck shares have dropped by around a third since the start of July 2024, amid investor worries over how the company will ...

The Republican Party has been able to repeal climate provisions enacted by the Inflation Reduction Act, the marquee legislation signed by President Joe Biden, but has left other parts of ...

The drug industry’s top lobbying group is appealing its latest loss in its challenge to Medicare’s Drug Price Negotiation ...

A federal appeals panel voted 2-to-1 against a group of international aid groups, ruling they did not have the legal standing to bring a lawsuit. Meanwhile, the Trump administration has ordered a ...

Drug companies have formed a new group to present lawmakers with research on what the industry sees as the negative impacts ...

The test run will be limited to the 10 drug products included on the Centers for Medicare and Medicaid Services (CMS) Medicare Drug Price Negotiation Selected Drug List, according to a notice ...

A normally hard-headed bench just endorsed President Biden’s scheme to dictate how much drugmakers can charge under Medicare.

The federal court dismissed a lawsuit from business chambers over the Medicare drug price negotiation program.